KROS R&D to Revenue
Keros Therapeutics Inc · R&D to Revenue
KROS R&D to Revenue
Latest reported0.00%period ending
KROS Quarterly R&D/Revenue (194.68% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
KROS r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 0% | |
| 4,386.1035% | |
| 4,652.4675% | |
| 136.8602% | |
| 239.4485% | |
| 23.058% | |
| 1,500.0329% | |
| 12,686.8557% | |
| 109,500% | |
| 46,093.9759% | |
| 26,218.8811% | |
| 426,750% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 94.17% | |
| 0% | |
| 9,983% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 166.44% | |
| 154.16% | |
| 179.88% | |
| 194.68% |